THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...

The FDA approves Lilly's Ebglyss based on data from ADvocate 1, ADvocate 2 and ADhere studies.

US drug giant also formally opens $800m expansion of obesity and diabetes medicines plant in Cork

Eli Lilly stock boasts both defensive and growth characteristics

Construction projects of major companies such as Intel, Diageo and Eli Lilly will be impacted.

A survey reveals 25% of adults are considering using weight loss drugs without a prescription, raising concerns about safety and health risks.

WEDNESDAY, Sept. 11, 2024 -- An experimental weight-loss pill appears to help people quickly shed pounds, a new study says. People who took the drug...

WEDNESDAY, Sept. 11, 2024 -- The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers...

Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...